| 1 | [SID103292465] | Active | EC50 | 1.3 | Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 1 hr by HTRF assay [AID669685, Type: other] | Mu-type opioid receptor [gi:2851402] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103292465 | | CID | 33741 | | Outcome | Active | | EC50 | 1.3 [uM] | | BioAssay | Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 1 hr by HTRF assay | | AID | 669685 | | BioAssay type | other | | Target | Mu-type opioid receptor [gi:2851402] | | PubMed | | | Data Table |  |
|
| 2 | [SID103292465] | Active | EC50 | 1.3 | Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 1 hr by HTRF assay [AID669685, Type: other] | Mu-type opioid receptor [gi:2851402] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103292465 | | CID | 33741 | | Outcome | Active | | EC50 | 1.3 [uM] | | BioAssay | Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 1 hr by HTRF assay | | AID | 669685 | | BioAssay type | other | | Target | Mu-type opioid receptor [gi:2851402] | | PubMed | | | Data Table |  |
|
| 3 | [SID103292465] | Active | EC50 | 1.3 | Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 1 hr by HTRF assay [AID669685, Type: other] | Mu-type opioid receptor [gi:2851402] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103292465 | | CID | 33741 | | Outcome | Active | | EC50 | 1.3 [uM] | | BioAssay | Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 1 hr by HTRF assay | | AID | 669685 | | BioAssay type | other | | Target | Mu-type opioid receptor [gi:2851402] | | PubMed | | | Data Table |  |
|
| 4 | [SID103292465] | Active | EC50 | 1.3 | Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 1 hr by HTRF assay [AID669685, Type: other] | Mu-type opioid receptor [gi:2851402] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103292465 | | CID | 33741 | | Outcome | Active | | EC50 | 1.3 [uM] | | BioAssay | Agonist activity at human mu opioid receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 1 hr by HTRF assay | | AID | 669685 | | BioAssay type | other | | Target | Mu-type opioid receptor [gi:2851402] | | PubMed | | | Data Table |  |
|
| 5 | [SID26663897] | Active | | | Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Active | | BioAssay | Aqueous Solubility from MLSMR Stock Solutions | | AID | 1996 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID48416650] | Active | | | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 48416650 | | CID | 33741 | | Outcome | Active | | BioAssay | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database | | AID | 1195 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID29215256] | Active | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_3, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 29215256 | | CID | 33741 | | Outcome | Active | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 8 | [SID29215256] | Active | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_24, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 29215256 | | CID | 33741 | | Outcome | Active | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 9 | [SID29215256] | Active | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_29, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 29215256 | | CID | 33741 | | Outcome | Active | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 10 | [SID29215256] | Active | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_26, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 29215256 | | CID | 33741 | | Outcome | Active | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 11 | [SID29215256] | Active | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_56, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 29215256 | | CID | 33741 | | Outcome | Active | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 12 | [SID26663897] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 13 | [SID26663897] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 14 | [SID29215256] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 29215256 | | CID | 33741 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 15 | [SID26663897] | Inactive | Potency | 2.9093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | Potency | 2.9093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 16 | [SID26663897] | Inactive | Potency | 2.9093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | Potency | 2.9093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 17 | [SID26663897] | Inactive | Potency | 2.9093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | Potency | 2.9093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 18 | [SID144205141] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 144205141 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 19 | [SID144205141] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 144205141 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID144205141] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 144205141 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 21 | [SID144205141] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 144205141 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 22 | [SID144205141] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 144205141 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 23 | [SID144205141] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 144205141 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 24 | [SID26663897] | Inactive | | | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity [AID602252, Type: screening] | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity | | AID | 602252 | | BioAssay type | screening | | Target | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] | | PubMed | | | Data Table |  |
|
| 25 | [SID26663897] | Inactive | | | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity [AID602252, Type: screening] | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity | | AID | 602252 | | BioAssay type | screening | | Target | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] | | PubMed | | | Data Table |  |
|
| 26 | [SID26663897] | Inactive | | | Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity [AID504414, Type: screening] | Golgi-associated PDZ and coiled-coil motif-containing protein isoform a [Homo sapiens] [gi:9966877] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504414 | | BioAssay type | screening | | Target | Golgi-associated PDZ and coiled-coil motif-containing protein isoform a [Homo sapiens] [gi:9966877] | | PubMed | | | Data Table |  |
|
| 27 | [SID26663897] | Inactive | | | Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity [AID504414, Type: screening] | Golgi-associated PDZ and coiled-coil motif-containing protein isoform a [Homo sapiens] [gi:9966877] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504414 | | BioAssay type | screening | | Target | Golgi-associated PDZ and coiled-coil motif-containing protein isoform a [Homo sapiens] [gi:9966877] | | PubMed | | | Data Table |  |
|
| 28 | [SID26663897] | Inactive | | | qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) [AID624414, Type: screening] | MCOLN1 gene product [Homo sapiens] [gi:10092597] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) | | AID | 624414 | | BioAssay type | screening | | Target | MCOLN1 gene product [Homo sapiens] [gi:10092597] | | PubMed | | | Data Table |  |
|
| 29 | [SID26663897] | Inactive | | | qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) [AID624415, Type: screening] | MCOLN1 gene product [Homo sapiens] [gi:10092597] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) | | AID | 624415 | | BioAssay type | screening | | Target | MCOLN1 gene product [Homo sapiens] [gi:10092597] | | PubMed | | | Data Table |  |
|
| 30 | [SID26663897] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7) [AID434973, Type: screening] | SUMO1/sentrin specific peptidase 7 [Homo sapiens] [gi:120538355] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7) | | AID | 434973 | | BioAssay type | screening | | Target | SUMO1/sentrin specific peptidase 7 [Homo sapiens] [gi:120538355] | | PubMed | | | Data Table |  |
|
| 31 | [SID26663897] | Inactive | | | Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen [AID1456, Type: other] | electroneutral potassium-chloride cotransporter KCC2 [Homo sapiens] [gi:12003227] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen | | AID | 1456 | | BioAssay type | other | | Target | electroneutral potassium-chloride cotransporter KCC2 [Homo sapiens] [gi:12003227] | | PubMed | | | Data Table |  |
|
| 32 | [SID26663897] | Inactive | | | uHTS Colorimetric assay for identification of inhibitors of Scp-1 [AID493091, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | uHTS Colorimetric assay for identification of inhibitors of Scp-1 | | AID | 493091 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 33 | [SID26663897] | Inactive | Potency | | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 34 | [SID26663897] | Inactive | Potency | | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 35 | [SID26663897] | Inactive | Potency | | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 36 | [SID26663897] | Inactive | Potency | | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 37 | [SID26663897] | Inactive | Potency | | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 38 | [SID26663897] | Inactive | Potency | | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 39 | [SID26663897] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 40 | [SID26663897] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 41 | [SID26663897] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 42 | [SID26663897] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 43 | [SID26663897] | Inactive | | | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493012, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493012 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 44 | [SID26663897] | Inactive | Potency | | qHTS for Inhibitors of Vif-A3G Interactions: qHTS [AID602310, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3G Interactions: qHTS | | AID | 602310 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 45 | [SID26663897] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 46 | [SID26663897] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 47 | [SID26663897] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 48 | [SID26663897] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 49 | [SID26663897] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 50 | [SID26663897] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26663897 | | CID | 33741 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|